medigraphic.com
ISSN 2448-5640 (Print)
Diario Oficial de la Sociedad Mexicana de Cirugía Cardiaca, A.C., y del Colegio Mexicano de Cirugía Cardiovascular y Torácica, A.C.

2021, Number 2

<< Back

Cir Card Mex 2021; 6 (2)

The Latin American Association of Cardiac and Endovascular Surgery statement regarding the recently released 2020 ACC/AHA Guidelines for the Management of Patients with Valvular Heart Disease

Dayan V, García-Villarreal OA, Escobar A, Ferrari J, Quintana E, Marín-Cuartas M, Almeida R

Language: English
References: 5
Page: 58-60
PDF size: 111.24 Kb.


Text Extraction

Scientific evidence in the cardiological arena has progressed enormously in the last couple of years. It is a huge challenge for respected societies such as AHA and ACC to undertake the burden of providing to the world their recommendations for clinical practice based on this evidence. The Latinamerican Association of Cardiac and Endovascular Surgery (LACES) would like to thank the authors involved in such a task.
As a growing association that represents an economic and healthcare reality that is different from others, we have decided to carefully select guidelines that consider our socio-economic situation. As such, in this statement, we will highlight the aspects of the recently released AHA/ACC Guidelines for the Management of Patients with Valvular Heart Disease 2020 with which we disagree intending to support Latin-American surgeons in their practice.


REFERENCES

  1. Otto CM, Nishimura RA, Bonow RO, Carabello BA, Erwin JP 3rd, Gentile F, et al. 2020 ACC/AHA Guideline for the Management of Patients With Valvular HeartDisease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation2020; doi: 10.1161/CIR.0000000000000932.

  2. Leon MB, Smith CR, Mack MJ, Makkar RR, Svensson LG, Kodali SK et al.;PARTNER 2 Investigators. Transcatheter or surgical aortic-valve replace- ment inintermediate-risk patients. N Engl J Med 2016;374:1609–20.

  3. Stone GW, Lindenfeld J, Abraham WT, Kar S, Lim DS, Mishell JM et al.; COAPTInvestigators. Transcatheter mitral-valve repair in patients with heart failure. NEngl J Med 2018;379:2307–18.

  4. Obadia JF, Messika-Zeitoun D, Leurent G, Iung B, Bonnet G, Piriou N et al.;MITRA-FR Investigators. Percutaneous repair or medical treatment for secondarymitral regurgitation. N Engl J Med 2018;379:2297–306.

  5. Feldman T, Kar S, Elmariah S, Smart SC, Trento A, Siegel RJ et al.; EVERESTII Investigators. Randomized comparison of percutaneous re- pair and surgeryfor mitral regurgitation: 5-year results of EVEREST II. J Am Coll Cardiol2015;66:2844–54.




2020     |     www.medigraphic.com